NCKAP1L
protein-codingNCK associated protein 1 like
Gene summary
This gene encodes a member of the HEM family of tissue-specific transmembrane proteins which are highly conserved from invertebrates through mammals. This gene is only expressed in hematopoietic cells. The encoded protein is a part of the Scar/WAVE complex which plays an important role in regulating cell shape in both metazoans and plants. Alternatively spliced transcript variants encoding different isoforms have been found.[provided by RefSeq, May 2010]
- HEM1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~50.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0033551
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0033551
Submitter: ClinGen
*NKACP1*L was first reported in relation to autosomal recessive immunodeficiency 72 with autoinflammation in 2020 simultaneously by three separate authors (PMIDs: 32646852, 32647003, 32766723). Patients reported with this disorder can have recurrent bacterial infections, antibody abnormalities, lymphoproliferation, atopy, autoimmune disease and haemophagocytic lymphohistiocytosis. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Seven missense variants have been reported in nine probands in three publications are included in this curation. The heterozygous parents all appear unaffected. The mechanism of pathogenicity appears to be loss of function. NKACP1L encodes for HEM-1, a haematopoietic linage-restricted protein. A review on the function of HEM-1 can be found in PMID: 3902667. Experimental data includes functional studies (PMIDs: 32646852, 32647003, 32766723), mouse model (PMID: 32646852) and rescue in cultured cell lines (PMIDs: 32646852, 32647003). More experimental evidence is available in the literature, but the maximum score for genetic evidence experimental evidence (6 pts.) has been reached. In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen PIRD GCEP on the meeting date 9th of June 2026 (SOP Version 12). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen PIRD GCEP on the meeting date 9th of June 2026 (SOP Version 12).
Inheritance Pattern: AR
Disease ID:MONDO:0021094
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious
Intervention: Allergy/Immunology/Infectious
Rationale: The condition can involve early-onset and severe infections, as well as other immunologic manifestations, and awareness may allow early and aggressive treatment of infections; Medical management of autoimmune disease (with immunomodulatory agents) has been described as beneficial in some individuals
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to NCKAP1L variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_005337.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 170 | 5 | 177 | ||
| missense | 2 | 8 | 171 | 12 | 193 | |
| nonsense | 4 | 4 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 1 | 2 | 3 | |||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 4 | 6 | ||
| Total | 3 | 11 | 183 | 182 | 5 | 384 |
Highest pathogenic variant AF is 0.00006517022
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_005328.2 | 31 | MANE Select | |
| Ensembl | ENSP00000293373.6 | 31 | MANE Select | |
| RefSeq | NP_001171905.1 | 30 | Standard | |
| Ensembl | ENSP00000445596.2 | 30 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Regulation of actin cytoskeleton - Homo sapiens (human)
- Hematopoietic Stem Cell Differentiation
- Microglia Pathogen Phagocytosis Pathway
- TYROBP Causal Network
- Neutrophil degranulation
Biological Process
- cell morphogenesis
- B cell homeostasis
- myeloid cell homeostasis
- chemotaxis
- cell migration
Molecular Function
- GTPase activator activity
- protein binding
- protein kinase activator activity
- protein-containing complex binding
- Rac GTPase binding
Cellular Component
- cytosol
- plasma membrane
- integral component of plasma membrane
- membrane
- secretory granule membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000293373
- Coding exons
- 31
- Length
- 46232
- Individuals with no LoFs
- 125707
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 41
- Defined
- 125748
- p
- 0.000163
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.48 | 456 | 631 | 0.723 | 0.0000341 | 7438 |
| Missense (PolyPhen) | 134 | 217.54 | 0.61597 | 2504 | ||
| Synonymous | 0.0300 | 229 | 230 | 0.997 | 0.0000114 | 2171 |
| Loss of Function | 5.88 | 13 | 63.6 | 0.204 | 0.00000336 | 730 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.00037 | 0.00037 | rare |
| European (Non-Finnish) | 0.00023 | 0.00023 | rare |
| South Asian | 0.00013 | 0.00013 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Essential hematopoietic-specific regulator of the actin cytoskeleton (Probable). Controls lymphocyte development, activation, proliferation and homeostasis, erythrocyte membrane stability, as well as phagocytosis and migration by neutrophils and macrophages (PubMed:16417406, PubMed:17696648). Component of the WAVE2 complex which signals downstream of RAC to stimulate F- actin polymerization. Required for stabilization and/or translation of the WAVE2 complex proteins in hematopoietic cells (By similarity). Exhibits complex cycles of activation and inhibition to generate waves of propagating the assembly with actin (PubMed:16417406). Also involved in mechanisms WAVE- independent to regulate myosin and actin polymerization during neutrophil chemotaxis (PubMed:17696648). {ECO:0000250|UniProtKB:Q8K1X4, ECO:0000269|PubMed:16417406, ECO:0000269|PubMed:17696648, ECO:0000303|PubMed:20969869}.;
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- LoFtool
- 0.664
- RVIS EVS
- -0.46
- RVIS percentile EVS
- 23.69
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.909
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |